Dr. Richard Mailman has spent decades working to get the Parkinson’s drug Tavapadon to patients. After tireless effort, the pharmaceutical company AbbVie has finally submitted the drug to the FDA for consideration. This is great news, because it has been over 50 years since a Parkinson’s drug has been approved. Tavapadon has the potential to improve the lives of so many people.
Find more info here.
Comments